307
Participants
Start Date
March 10, 2021
Primary Completion Date
December 23, 2023
Study Completion Date
December 23, 2023
Isavuconazole
antifungal agent
Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario Marques de Valdecilla, Santander
University Hospital Miguel Servet, Zaragoza
University Hospital of Cologne, Cologne
Hôpital Huriez CHU de Lille, Lille
Universitätsklinik Frankfurt, Frankfurt
Institut de Cancérologie, Strasbourg
Paris University, Paris
Klinikum rechts der Isar Technische Universität München, Munich
CHU de Limoges, Limoges
Comprehensive Cancer Center Ulm (CCCU), Ulm
Vall d'Hebron University Hospital, Barcelona
Fundació Clínic Per A La Recerca Biomèdica, Barcelona
Cambridge University Hospitals NHS Foundation Trust, Cambridge
King'S College Hospital Nhs Foundation Trust, London
Lead Sponsor
Pfizer
INDUSTRY